Validation and update of a prediction model for risk of relapse after cessation of anti-TNF treatment in Crohn’s disease

医学 克罗恩病 疾病 克罗恩病 内科学
作者
Sebastiaan ten Bokkel Huinink,D C de Jong,Daan Nieboer,Doranne Thomassen,Ewout Willem Steyerberg,Marcel G. W. Dijkgraaf,Alexander G L Bodelier,Rachel Louise West,Tessa E H Römkens,Frank Hoentjen,Rosalie C. Mallant–Hent,Bas A.C. van Tuyl,Wout G.N. Mares,Frank H.J. Wolfhagen,Gerard D. H. Dijkstra,Jurriën G.P. Reijnders,Nanne K.H. de Boer,Adriaan C.I.T.L. Tan,Petra G. Van Boeckel,Greetje J. Tack
出处
期刊:European Journal of Gastroenterology & Hepatology [Lippincott Williams & Wilkins]
卷期号:34 (10): 983-992 被引量:4
标识
DOI:10.1097/meg.0000000000002403
摘要

BACKGROUND: Anti-tumor necrosis factor (TNF) therapy is effective for the treatment of Crohn's disease. Cessation may be considered in patients with a low risk of relapse. We aimed to externally validate and update our previously developed prediction model to estimate the risk of relapse after cessation of anti-TNF therapy. METHODS: We performed a retrospective cohort study in 17 Dutch hospitals. Crohn's disease patients in clinical, biochemical or endoscopic remission were included after anti-TNF cessation. Primary outcome was a relapse necessitating treatment. Discrimination and calibration of the previously developed model were assessed. After external validation, the model was updated. The performance of the updated prediction model was assessed in internal-external validation and by using decision curve analysis. RESULTS: 486 patients were included with a median follow-up of 1.7 years. Relapse rates were 35 and 54% after 1 and 2 years. At external validation, the discriminative ability of the prediction model was equal to that found at the development of the model [c-statistic 0.58 (95% confidence interval (CI) 0.54-0.62)], though the model was not well-calibrated on our cohort [calibration slope: 0.52 (0.28-0.76)]. After an update, a c-statistic of 0.60 (0.58-0.63) and calibration slope of 0.89 (0.69-1.09) were reported in internal-external validation. CONCLUSION: Our previously developed and updated prediction model for the risk of relapse after cessation of anti-TNF in Crohn's disease shows reasonable performance. The use of the model may support clinical decision-making to optimize patient selection in whom anti-TNF can be withdrawn. Clinical validation is ongoing in a prospective randomized trial.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
柯楠吴完成签到,获得积分10
1秒前
cbh完成签到,获得积分10
1秒前
绿叶发布了新的文献求助10
1秒前
1秒前
2秒前
大刘发布了新的文献求助10
3秒前
3秒前
kk发布了新的文献求助10
4秒前
坚强飞扬发布了新的文献求助10
4秒前
5秒前
小薯条完成签到,获得积分10
6秒前
6秒前
6秒前
宋嘉新发布了新的文献求助10
6秒前
米缸发布了新的文献求助10
7秒前
7秒前
柯楠吴发布了新的文献求助10
7秒前
宋树立发布了新的文献求助30
7秒前
Lucas的应助被科研通管家采纳,获得10
7秒前
充电宝的应助被科研通管家采纳,获得10
7秒前
7秒前
852的应助被枫叶采纳,获得10
7秒前
完美世界的应助被科研通管家采纳,获得10
7秒前
星辰大海的应助被科研通管家采纳,获得10
7秒前
科研通AI2S的应助被科研通管家采纳,获得10
8秒前
烟花的应助被科研通管家采纳,获得10
8秒前
丘比特的应助被科研通管家采纳,获得10
8秒前
molihuakai的应助被科研通管家采纳,获得10
8秒前
无花果的应助被科研通管家采纳,获得10
8秒前
何永灿发布了新的文献求助10
8秒前
cdercder的应助被kklove采纳,获得10
8秒前
cdercder的应助被科研通管家采纳,获得10
8秒前
在水一方的应助被科研通管家采纳,获得10
8秒前
xy完成签到 ,获得积分10
9秒前
科研通AI2S的应助被科研通管家采纳,获得10
9秒前
YanJinyu发布了新的文献求助30
9秒前
9秒前
团子完成签到 ,获得积分10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163643
求助须知:如何正确求助?哪些是违规求助? 9557771
关于积分的说明 21741795
捐赠科研通 7754289
什么是DOI,文献DOI怎么找? 3428316
关于科研通互助平台的介绍 2552989
邀请新用户注册赠送积分活动 2472943